Salataz Special Precautions

Talk to the doctor, pharmacist or nurse before using SALATAZ 4 g/0.5 g powder for solution for infusion: If there are allergies. If there are several allergies, make sure to tell the doctor or other healthcare professional before receiving this product.
If suffering from diarrhoea before, or if diarrhoea is developed during or after the treatment. In this case, make sure to tell the doctor or other healthcare professional immediately. Do not take any medicine for the diarrhoea without first checking with the doctor.
If there are low levels of potassium in the blood. The doctor may want to check the kidneys before the patient takes this medicine and may perform regular blood tests during treatment.
If there are kidney or liver problems, or receiving haemodialysis. The doctor may want to check the kidneys before the patient takes this medicine, and may perform regular blood tests during treatment.
If taking certain medicines (called anticoagulants) to avoid an excess of blood clotting (see also Interactions) or any unexpected bleeding occurs during the treatment. In this case, the patient should inform the doctor or other healthcare professional immediately.
If convulsions are developed during the treatment. In this case, the patient should inform the doctor or other healthcare professional.
If patient has developed a new or worsening infection. In this case, they should inform the doctor or other healthcare professional.
Effect on laboratory tests: Tell the doctor or laboratory staff that SALATAZ 4 g/0.5 g powder for solution for infusion is being taken if blood or urine sample is to be provided.
SALATAZ 4 g/0.5 g powder for solution for infusion contains sodium: This medicinal product contains 9.44 mmol (217 mg) of sodium per vial of powder for solution for infusion. This should be taken into consideration if the patient is on a controlled sodium diet.
Driving and using machines: The use of SALATAZ 4 g/0.5 g powder for solution for infusion is not expected to affect the ability to drive or use machines.
Use in Children: Piperacillin / tazobactam is not recommended for use in children below the age of 2 years due to insufficient data on safety and effectiveness.